Eudragit: A Novel Carrier for Controlled Drug Delivery in Supercritical Antisolvent Coprecipitation

Overview

Journal Polymers (Basel)

Publisher MDPI

Date 2020 Jan 23

PMID 31963638

Citations 16

Authors

Paola Franco

Iolanda De Marco

Affiliations

Soon will be listed here.

Abstract

In this work, the supercritical antisolvent (SAS) process was used to coprecipitate Eudragit L100-55 (EUD) with diclofenac (DICLO) and theophylline (THEOP), with the aim of obtaining composite microparticles with a prolonged drug release for oral delivery. Working at the optimized conditions in terms of pressure and overall concentration in the liquid solution (10.0 MPa and 50 mg/mL), microparticles of EUD/DICLO 20/1 and 10/1 / were produced with a mean size of 2.92 µm and 1.53 µm, respectively. For the system EUD/THEOP, well-defined spherical microspheres with a mean diameter ranging from 3.75 µm and 5.93 µm were produced at 12.0 MPa. The produced composite systems were characterized by various techniques, such as scanning electron microscopy, differential scanning calorimetry, X-ray microanalysis, FT-IR and UV-vis spectroscopy. Dissolution studies showed the potential of EUD to prolong the drug release, significantly, up to a few days.

Citing Articles

Mechanochemical Approach to Obtaining a Multicomponent Fisetin Delivery System Improving Its Solubility and Biological Activity.

Rosiak N, Tykarska E, Cielecka-Piontek J Int J Mol Sci. 2024; 25(7).

PMID: 38612460 PMC: 11011862. DOI: 10.3390/ijms25073648.

The Study of Amorphous Kaempferol Dispersions Involving FT-IR Spectroscopy.

Rosiak N, Tykarska E, Cielecka-Piontek J Int J Mol Sci. 2023; 24(24).

PMID: 38138984 PMC: 10742969. DOI: 10.3390/ijms242417155.

Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.

Han S, Lee P, Choi H Pharmaceutics. 2023; 15(8).

PMID: 37631328 PMC: 10458847. DOI: 10.3390/pharmaceutics15082114.

Coprecipitation of Class II NSAIDs with Polymers for Oral Delivery.

De Marco I Polymers (Basel). 2023; 15(4).

PMID: 36850237 PMC: 9959069. DOI: 10.3390/polym15040954.

Particle preparation of pharmaceutical compounds using supercritical antisolvent process: current status and future perspectives.

Kumar R, Thakur A, Kali G, Pitchaiah K, Arya R, Kulabhi A Drug Deliv Transl Res. 2022; 13(4):946-965.

PMID: 36575354 DOI: 10.1007/s13346-022-01283-7.

References

Ceballos A, Cirri M, Maestrelli F, Corti G, Mura P . Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Farmaco. 2005; 60(11-12):913-8. DOI: 10.1016/j.farmac.2005.07.002. View

Huang Q, Yu H, Ru Q . Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci. 2010; 75(1):R50-7. DOI: 10.1111/j.1750-3841.2009.01457.x. View

Moustafine R, Kabanova T, Kemenova V, van den Mooter G . Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release. 2005; 103(1):191-8. DOI: 10.1016/j.jconrel.2004.11.031. View

Moustafine R, Zaharov I, Kemenova V . Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm. 2005; 63(1):26-36. DOI: 10.1016/j.ejpb.2005.10.005. View

Ochoa L, Igartua M, Hernandez R, Gascon A, Pedraz J . Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. J Pharm Pharm Sci. 2005; 8(2):132-40. View

Hamman J . Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. Mar Drugs. 2010; 8(4):1305-22. PMC: 2866488. DOI: 10.3390/md8041305. View

Khan M, PREBEG Z, Kurjakovic N . A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. J Control Release. 1999; 58(2):215-22. DOI: 10.1016/s0168-3659(98)00151-5. View

Lee S, Kim M, Kim J, Park H, Woo J, Lee B . Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique. J Microencapsul. 2006; 23(7):741-9. DOI: 10.1080/09687860600945552. View

Mengozzi G, Intorre L, Bertini S, Giorgi M, Soldani G . Comparative bioavailability of two sustained-release theophylline formulations in the dog. Pharmacol Res. 1999; 38(6):481-5. DOI: 10.1006/phrs.1998.0394. View

10.

Brzezinski M, Kost B, Wedepohl S, Socka M, Biela T, Calderon M . Stereocomplexed PLA microspheres: Control over morphology, drug encapsulation and anticancer activity. Colloids Surf B Biointerfaces. 2019; 184:110544. DOI: 10.1016/j.colsurfb.2019.110544. View

11.

Vehring R . Pharmaceutical particle engineering via spray drying. Pharm Res. 2007; 25(5):999-1022. PMC: 2292490. DOI: 10.1007/s11095-007-9475-1. View

12.

Todd P, Sorkin E . Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1988; 35(3):244-85. DOI: 10.2165/00003495-198835030-00004. View

13.

Nykamp G, Carstensen U, Muller B . Jet milling--a new technique for microparticle preparation. Int J Pharm. 2002; 242(1-2):79-86. DOI: 10.1016/s0378-5173(02)00150-3. View

14.

Majeed A, Ranjha N, Hanif M, Abbas G, Khan M . DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE. Acta Pol Pharm. 2018; 74(2):565-578. View

15.

Duarte A, Roy C, Vega-Gonzalez A, Duarte C, Subra-Paternault P . Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques. Int J Pharm. 2006; 332(1-2):132-9. DOI: 10.1016/j.ijpharm.2006.09.041. View

16.

Yadav H, Shivakumar H . In Vitro and In Vivo Evaluation of pH-Sensitive Hydrogels of Carboxymethyl Chitosan for Intestinal Delivery of Theophylline. ISRN Pharm. 2012; 2012:763127. PMC: 3395187. DOI: 10.5402/2012/763127. View

17.

McGinity , ODonnell . Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev. 2000; 28(1):25-42. DOI: 10.1016/s0169-409x(97)00049-5. View

18.

Tonnesen H, Karlsen J . Alginate in drug delivery systems. Drug Dev Ind Pharm. 2002; 28(6):621-30. DOI: 10.1081/ddc-120003853. View